Air Pollution Control and Health Economic Burdens: Evidence From a Megacity in China From 2014 to 2022

Author(s)

Zheng B1, Chen J2, Zhang Q3, Zhang H2
1Duke Kunshan University, Kunshan, Jiangsu Province, China, 2Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, China, 3Guangdong Medical Economics and Health Promotion Research Center, Guangzhou, China, 44, China

OBJECTIVES: The Guangdong-Hong Kong-Macao Greater Bay Area is a pioneer for air pollution control in China. This study investigated the health and economic benefits of air pollution control measures in Shenzhen, which has made great achievement in air quality improvement, aiming to empirically demonstrate the health and economic significance of air pollution control.

METHODS: The pollutants PM2.5 and O3 were selected as the main focuses of our analysis, and the proportional hazards model based on Poisson regression, the statistical life value, the cost of illness and the willingness-to-pay method were all employed to assess the health-economic benefits of air pollution control from 2014 to 2022, and to further quantify the impacts of short-term public health policies on air quality and social health-economic burdens.

RESULTS: Prior to COVID-19, health hazards and economic burdens caused by PM2.5 declined significantly as air quality improved, as premature deaths reduced by a total of 1,759 (95% Cl: 867-2,624) and $27.97 million (95% Cl: $13.89-41.39 million) was saved in economic costs. However, the health hazards and economic burden caused by O3 had shown a fluctuating upward trend. During the COVID-19 pandemic, the Chinese government had implemented strict lockdown policies, which indirectly reduced health hazards and economic burdens caused by various pollutants.

CONCLUSIONS: The effective implementation of air pollution control policies can help reduce health hazards and health economic burdens. Governments should recognize the effects and consequences of public health policy implementation, and strengthen the transparency and effectiveness of public health policymaking, thus safeguarding ecological security of China and the world.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Acceptance Code

P5

Topic

Epidemiology & Public Health

Topic Subcategory

Public Health, Safety & Pharmacoepidemiology

Disease

cardiovascular-disorders-including-mi-stroke-circulatory, no-additional-disease-conditions-specialized-treatment-areas, respiratory-related-disorders-allergy-asthma-smoking-other-respiratory

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×